Press releases Mar 08, 2023
Strategic collaboration in Estonia progresses: Nightingale Health completes the analysis of 200,000 Estonian Biobank samples
Press release, 8 March 2023 at 1:30 p.m. (EET)
Nightingale Health Plc (“Nightingale Health”), a technology company promoting preventative health with its proprietary health risk detection platform, has analyzed and delivered to Estonian Biobank the analysis results from blood samples of 200,000 Estonian Biobank participants.
Nightingale Health and Estonian Biobank announced in 2021 their long-term strategic collaboration constituting an initiative to empower the population of Estonia with modern tools of personalized medicine to realize early disease prevention. The participants of the Estonian Biobank represent approximately 20% of the Estonian adult population, which makes it a very significant health database also on an international scale. The completion of the analysis of 200,000 samples further validates the suitability of Nightingale Health’s health risk detection platform for population-level health initiatives.
The results analyzed from each Estonian Biobank’s blood sample by Nightingale Health’s blood analysis technology include 250 biomarkers, of which 39 are clinically validated and can be used in the same way as traditional clinical biomarkers. The collaboration between Nightingale Health and Estonian Biobank enables the biomarker data from 200,000 samples to be used to advance scientific medical research. In addition, the data will be used to bring novel health insights, such as health risk estimates, to the biobank participants to enable disease prevention.
For further information, please contact:
Teemu Suna, CEO
About Nightingale Health
Nightingale Health is The Preventative Health Company. Staying healthy is one of the top priorities in human life. Our health has a profound impact on our quality of life, and it’s also strongly connected to the lives of those close to us. Nightingale Health enables prevention by combining the power of our in-house developed, advanced blood analysis technology with unprecedented access to global health repositories and world-leading medical research. With this combination, we go beyond the traditional healthcare and wellbeing tools: We provide the scientific connection to multiple health and disease outcomes and the ability to predict future healthy years.